HCW Biologics Inc.
HCW Biologics Inc.（HCWB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · HCWB · 截至 2026年6月9日
活动摘要
买入笔数
12
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
HCW Biologics Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
HCWB 季度内部人买卖趋势
HCWB 内幕交易卖出 · HCWB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · HCWB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
HCWB 高管卖出股份 · HCWB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 22, 2026 | Wong Hing C CEO · Director | Purchase | 113,879 | $160K | Form 4 |
| May 22, 2026 | GARRETT SCOTT T Director | Purchase | 177,936 | $250K | Form 4 |
| May 22, 2026 | Byam Rebecca CFO | Purchase | 14,235 | $20K | Form 4 |
| May 16, 2025 | Wong Hing C CEO · Director | Purchase | 8,054 | $60K | Form 4 |
| May 16, 2025 | Winer Gary M Director | Purchase | 1,342 | $10K | Form 4 |
| May 16, 2025 | GARRETT SCOTT T Director | Purchase | 13,423 | $100K | Form 4 |
| May 8, 2025 | Winer Gary M Director | Purchase | 2,308 | $60K | Form 4 |
| May 8, 2025 | Wong Hing C CEO · Director | Purchase | 92,500 | $2.40M⚡ | Form 4 |
| May 8, 2025 | GARRETT SCOTT T Director | Purchase | 5,385 | $140K | Form 4 |
| May 8, 2025 | Byam Rebecca CFO | Purchase | 8,462 | $220K | Form 4 |
| May 8, 2025 | Flowers Lee SVP of Business Development | Purchase | 962 | $25K | Form 4 |
| May 8, 2025 | Greene Rick S. Director | Purchase | 962 | $25K | Form 4 |
| Feb 20, 2024 | Wong Hing C CEO · Director | Award | 739,288 | $1.04M⚡ | Form 4 |
| Feb 20, 2024 | Greene Rick S. Director | Award | 35,714 | $50K | Form 4 |
| Feb 20, 2024 | Giles Lisa M. Director | Award | 35,715 | $50K | Form 4 |
| Feb 20, 2024 | GARRETT SCOTT T Director | Award | 142,858 | $200K | Form 4 |
| Feb 20, 2024 | Flowers Lee SVP of Business Development | Award | 71,429 | $100K | Form 4 |
| Feb 20, 2024 | Byam Rebecca CFO | Award | 760,714 | $1.06M⚡ | Form 4 |
| Dec 11, 2023 | Rhode Peter See Remarks | Option | 14,000 | $2K | Form 4 |
| Dec 8, 2023 | Flowers Lee SVP of Business Development | Option | 7,501 | $1K | Form 4 |
| Nov 17, 2023 | Rhode Peter See Remarks | Option | 15,000 | $2K | Form 4 |
| Oct 19, 2023 | Byam Rebecca CFO | Option | 47,249 | $7K | Form 4 |
| Sep 14, 2023 | Wong Hing C CEO · Director | Purchase | 1,800 | $4K | Form 4 |
| Sep 14, 2023 | Winer Gary M Director | Purchase | 879 | $2K | Form 4 |
| Sep 14, 2023 | Winer Gary M Director | Purchase | 162 | $337 | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HCWB 内幕交易
HCWB 内幕交易
HCW Biologics Inc.（HCWB）内幕交易数据来源于公司内部人（包括Wong Hing C (CEO · Director), GARRETT SCOTT T (Director), Byam Rebecca (CFO)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。HCWB内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看HCW Biologics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
HCWB 内幕交易 · 5个问题HCW Biologics Inc.（HCWB）的内部人包括高管和董事，如Wong Hing C (CEO · Director), GARRETT SCOTT T (Director), Byam Rebecca (CFO)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026